(Q37174279)

18 August 2017

1 reference

title

Cyclooxygenase-2 in cancer and angiogenesis (English)

1 reference

18 August 2017

1 reference

Mehmet Sahin

1

1 reference

18 August 2017

Emel Sahin

series ordinal

2

1 reference

18 August 2017

Saadet Gümüslü

series ordinal

3

1 reference

18 August 2017

language of work or name

1 reference

27 May 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

60

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

242-253

1 reference

Angiogenesis in cancer, vascular, rheumatoid and other disease

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Atherosclerosis and angiogenesis. Its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Angiogenesis in mice with chronic airway inflammation: strain-dependent differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: history and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Cyclooxygenase-2: a therapeutic target in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

The structure of mammalian cyclooxygenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

21 January 2018

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Aspirin as an antiplatelet drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Basic biology and clinical application of specific cyclooxygenase-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Discovery and design of selective cyclooxygenase-2 inhibitors as non-ulcerogenic, anti-inflammatory drugs with potential utility as anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

COX-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Prostaglandins and leukotrienes: advances in eicosanoid biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Prostaglandins and gangliosides of tumor microenvironment: their role in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Non-steroidal anti-inflammatory drugs and the chemoprevention of colorectal and oesophageal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

NSAID use and decreased risk of gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Cyclooxygenase‐2 and gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Immunohistochemical expression of cyclooxygenase-2 in skin cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Transforming growth factor-beta1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin-1 in human dermal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: a study in the hairless mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Inhibition of cutaneous ultraviolet light B–mediated inflammation and tumor formation with topical celecoxib treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Expression of cyclooxygenase-2 in prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: possible role in tumor promotion and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Is cyclooxygenase-2 the alpha and the omega in cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

COX-2 expression and tumor angiogenesis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Host cyclooxygenase-2 modulates carcinoma growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

HIF-1 and tumor progression: pathophysiology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Oxygen-dependent and -independent regulation of HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

COX-2 inhibitors. A new class of antiangiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319708318378

21 January 2018

Identifiers

DOI

10.1177/0003319708318378

1 reference

18 August 2017

1 reference